국가: 아일랜드
언어: 영어
출처: HPRA (Health Products Regulatory Authority)
NIFEDIPINE
Clear Pharmacy
C08CA05
NIFEDIPINE
30 Milligram
Tablet Prolonged Release
Product subject to prescription which may be renewed (B)
Dihydropyridine derivatives
Authorised
2011-01-21
PACKAGE LEAFLET - INFORMATION FOR THE USER ADALAT® LA 30MG PROLONGED RELEASE TABLET nifedipine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have more questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET 1. What Adalat LA is 2. Before you take Adalat LA 3. How you take Adalat LA 4. Possible side effects 5. How to store Adalat LA 6. Further information 1. WHAT ADALAT LA IS Adalat LA contains nifedipine, which belongs to a group of medicines called _calcium antagonists._ ADALAT LA IS USED TO TREAT HIGH BLOOD PRESSURE OR ANGINA _(chest pain). _ _For high blood pressure_: Adalat LA works by relaxing and expanding the blood vessels. This makes the blood flow more easily and lowers blood pressure. Lower blood pressure reduces the strain on your heart. _For angina_: Adalat LA works by relaxing and expanding the arteries supplying the heart. This allows more blood and oxygen to reach the heart and decreases the strain on it. Your angina attacks will be less severe and less frequent if there is less strain on the heart. 2. BEFORE YOU TAKE ADALAT LA DO NOT TAKE ADALAT LA: IF YOU HAVE HAD A HEART ATTACK within the last month. IF YOU GET A SUDDEN ANGINA ATTACK. Adalat LA will not help relieve symptoms of angina quickly. IF YOU HAVE UNSTABLE ANGINA. IF YOU ARE 전체 문서 읽기
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Adalat LA 30mg Prolonged-Release Tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains 30 mg nifedipine. Excipients: Sodium For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Prolonged-release film-coated tablet. _Product imported from Romania:_ Pink, circular convex tablets with Adalat 30 marked on one side. 4 CLINICAL PARTICULARS As per PA1410/025/006 5 PHARMACOLOGICAL PROPERTIES As per PA1410/025/006 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Hypromellose (5cP) Magnesium stearate Polyethene oxide Iron oxide red (E172) Sodium chloride Ethyl cellulose Macrogol (3350) Hydroxypropyl cellulose Hypromellose (3cP) Titanium dioxide (E171) Propylene glycol _black ink lettering_ Shellac Black iron oxide (E172) Propylene glycol Ammonium hydroxide 28% 6.2 INCOMPATIBILITIES Not applicable. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 12/06/2015_ _CRN 2160471_ _page number: 1_ 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 30°C. Store in the original container. The tablets should be protected from strong light. Do not remove the tablet from the blister until immediately before use. 6.5 NATURE AND CONTENTS OF CONTAINER Blisters packed into a cardboard carton of 28 tablets 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER Clear Pharmacy 157-173 Roden Street Belfast BT12 5QA United Kingdom 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1596/035/001 9 DATE OF FIRST AUTHORISATION 전체 문서 읽기